login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
PREDICTIVE ONCOLOGY INC (POAI) Stock News
NASDAQ:POAI -
US74039M3097
-
Common Stock
0.8749
USD
-0.04 (-4.38%)
Last: 8/29/2025, 8:00:01 PM
0.8
USD
-0.07 (-8.56%)
Pre-Market:
9/2/2025, 8:00:02 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
POAI Latest News, Press Relases and Analysis
All
Press Releases
13 days ago - By: Kahn Swick & Foti, LLC
- Mentions:
RENB
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
19 days ago - By: The Motley Fool
POAI Reports Earnings
19 days ago - By: Predictive Oncology Inc.
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
5 months ago - By: Benzinga
What's Going On With Predictive Oncology Shares Tuesday?
19 days ago - By: Predictive Oncology Inc.
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
2 months ago - By: Predictive Oncology Inc.
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
2 months ago - By: Predictive Oncology Inc.
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
2 months ago - By: Predictive Oncology Inc.
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
2 months ago - By: Predictive Oncology Inc.
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
3 months ago - By: Predictive Oncology Inc.
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
3 months ago - By: Predictive Oncology Inc.
- Mentions:
LH
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
3 months ago - By: Predictive Oncology Inc.
Court Denies Renovaro Motion for an Expedited Trial in July
3 months ago - By: Predictive Oncology Inc.
Court Denies Renovaro Motion for an Expedited Trial in July
3 months ago - By: Renovaro Inc
- Mentions:
RENB
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
3 months ago - By: Renovaro Inc
- Mentions:
RENB
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
3 months ago - By: Predictive Oncology Inc.
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
3 months ago - By: Predictive Oncology Inc.
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
4 months ago - By: Predictive Oncology Inc.
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
4 months ago - By: Predictive Oncology Inc.
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
4 months ago - By: Predictive Oncology Inc.
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
4 months ago - By: Predictive Oncology Inc.
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
4 months ago - By: FN Media Group LLC
- Mentions:
AVAI
TDOC
TEM
GEHC
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
4 months ago - By: Zacks Investment Research
- Mentions:
SENS
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
5 months ago - By: Predictive Oncology Inc.
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
5 months ago - By: Benzinga
- Mentions:
PIII
PTIX
CPHI
BCLI
...
12 Health Care Stocks Moving In Friday's After-Market Session
5 months ago - By: Renovaro Inc
- Mentions:
RENB
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
4 months ago - By: FN Media Group LLC
- Mentions:
AVAI
RXRX
TEM
ADMA
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
5 months ago - By: Predictive Oncology Inc.
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
5 months ago - By: Predictive Oncology Inc.
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
Please enable JavaScript to continue using this application.